Practical Guidelines for Managing Patients With Psoriasis on Biologics: An Update
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Practical Guidelines for Managing Patients With Psoriasis on Biologics: An Update
Authors
Keywords
-
Journal
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
Volume 23, Issue 1_suppl, Pages 3S-12S
Publisher
SAGE Publications
Online
2019-01-10
DOI
10.1177/1203475418811347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR)
- (2018) Bruce Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta-analysis
- (2017) Fukiko Komaki et al. JOURNAL OF AUTOIMMUNITY
- Biologic Therapy in Psoriasis: Perspectives on Associated Risks and Patient Management
- (2017) Kim A. Papp et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti–Tumor Necrosis Factor Agents During Pregnancy
- (2016) Gabriella Bröms et al. Clinical Gastroenterology and Hepatology
- Risk of Herpes Zoster in Individuals on Biologics, Disease-Modifying Antirheumatic Drugs, and/or Corticosteroids for Autoimmune Diseases: A Systematic Review and Meta-Analysis
- (2016) Fawziah Marra et al. Open Forum Infectious Diseases
- To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis
- (2015) Christine S. Ahn et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures
- (2015) W. Bakkour et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Original paper Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis
- (2015) Magdalena M. Pirowska et al. Postepy Dermatologii i Alergologii
- Systemic Therapy for Psoriasis and the Risk of Herpes Zoster
- (2015) Guy Shalom et al. JAMA Dermatology
- Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
- (2015) Robert E. Kalb et al. JAMA Dermatology
- Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease
- (2014) Neeraj Narula et al. INFLAMMATORY BOWEL DISEASES
- Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
- (2014) Valentina Germano et al. Journal of Translational Medicine
- Japanese guidance for use of biologics for psoriasis (the 2013 version)
- (2013) Mamitaro Ohtsuki et al. JOURNAL OF DERMATOLOGY
- Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion
- (2013) M.-A. Richard et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies
- (2013) C. Pouplard et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions
- (2013) L. Adelzadeh et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Mycobacterial diseases and antitumour necrosis factor therapy in USA
- (2012) KL Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability
- (2012) M. Fallahi-Sichani et al. JOURNAL OF IMMUNOLOGY
- Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study
- (2012) K. Papp et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Infections and Biologic Therapy in Rheumatoid Arthritis
- (2012) Kevin L. Winthrop RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Salmonella mycotic aneurysm in a patient receiving etanercept for rheumatoid arthritis
- (2011) Amandine Quatre et al. ARTHRITIS AND RHEUMATISM
- Association between psoriasis and incident cancer: the Iowa’s Women’s Health Study
- (2011) Anna E. Prizment et al. CANCER CAUSES & CONTROL
- Ustekinumab
- (2011) Jamie D. Croxtall DRUGS
- Biologics and Infections: Lessons from Tumor Necrosis Factor Blocking Agents
- (2011) Robert S. Wallis INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient
- (2010) Sharmeel K Wasan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2010) S. van Assen et al. ANNALS OF THE RHEUMATIC DISEASES
- Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
- (2010) Johan Askling et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Vaccinations in patients with immune-mediated inflammatory diseases
- (2010) J.-F. Rahier et al. RHEUMATOLOGY
- Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
- (2009) M. J. SHALE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of Psoriasis With Coronary Artery, Cerebrovascular, and Peripheral Vascular Diseases and Mortality
- (2009) Srjdan Prodanovich et al. ARCHIVES OF DERMATOLOGY
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies
- (2009) Luigi Naldi CLINICS IN DERMATOLOGY
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
- (2009) N. N. Mehta et al. EUROPEAN HEART JOURNAL
- The Risk of Stroke in Patients with Psoriasis
- (2009) Joel M. Gelfand et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: ‘AGREE-ing’ on a common base for European evidence-based psoriasis treatment guidelines
- (2009) A Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris
- (2009) D Pathirana et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies
- (2008) Rieke J. B. Driessen et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis
- (2008) William Huang et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- TNFα blockade in human diseases: Mechanisms and future directions
- (2007) Maida Wong et al. CLINICAL IMMUNOLOGY
- From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis
- (2007) Mark Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started